Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Fabad Journal of Pharmaceutical Sciences is Scopus-indexed (Q3, CiteScore 1.1). Published by Society of Pharmaceutical Sciences of Ankara (FABAD).
Checked against the index lists dated .
ISSN 1300-4182Verify ISSN ↗
Publisher: Society of Pharmaceutical Sciences of Ankara (FABAD)
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 134 / 191 | 30th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2003–present (also 1999–2001), best quartile Q3, CiteScore 1.1.
Fabad Journal of Pharmaceutical Sciences is Q3 in Pharmaceutical Science (rank 134 of 191), by CiteScore 2025.
Fabad Journal of Pharmaceutical Sciences is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.1, quartile Q3, 30th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.211, quartile Q3, with an H-index of 23.
Fabad Journal of Pharmaceutical Sciences is published by Society of Pharmaceutical Sciences of Ankara (FABAD). Its ISSN is 1300-4182.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Fabad Journal of Pharmaceutical Sciences has an h-index of 7 and a 2-year mean of 0.34 citations per paper (OpenAlex). Its Scopus CiteScore is 1.1, quartile Q3. On 2-year citations it ranks #143 of 177 Scopus journals in Pharmaceutical Science.
Fabad Journal of Pharmaceutical Sciences published 57 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2025–2026), authors are most often from Türkiye (63.2%), Indonesia (13.5%) and India (12.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.